Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bushen fangchuan
- Development stage
- Unknown
- Lead developer
- Taiji Group
- Administration
- Oral
01
Overview
Bushen Fangchuan is a Traditional Chinese Medicine (TCM) herbal formula developed by Taiji Group Fuling Pharmaceutical Factory for the treatment of respiratory diseases, including bronchial asthma and chronic obstructive pulmonary disease (COPD). The preparation, typically administered as a tablet or capsule, consists of eight herbal ingredients designed to "warm yang and tonify the kidney" according to TCM principles. Mechanistically, it demonstrates anti-inflammatory effects by reducing pro-inflammatory cytokines such as IL-8 and IL-17 while increasing levels of the anti-inflammatory cytokine IL-10 and plasma cortisol. Clinical trials have shown its efficacy in improving lung function (FEV1, VC), reducing the frequency of acute exacerbations, and enhancing the quality of life in patients with moderate to severe stable COPD.
- Brand names
- Bushen Fangchuan TabletBushen Fangchuan Capsule
- Other names
- BF tablet
02
Targets
IL10 (Interleukin-10)IL8 (C-X-C Motif Chemokine Ligand 8)IL-17A (Interleukin-17A)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on bushen fangchuan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bushen fangchuan.